Given the promise of combination cancer therapy, many drug discovery programmes are aiming to identify compounds with additive or synergistic effects. Using Drosophila, Edwards et al. report a system to screen for agents that enhance the anti-cancer effects of radiation. Following initial screens revealing microtubule poisons as candidates, they analyse one candidate, maytansinol, in Drosophila cells and larvae, and in human cancer cells. Their results show that this agent’s actions are p53-dependent and that they differ in vitro versus in vivo, highlighting the importance of studying drug effects in a whole organism.
- Written by editorial staff. © 2011. Published by The Company of Biologists Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.